Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06390683
Other study ID # HUS/11940/2022
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date September 30, 2027

Study information

Verified date April 2024
Source Natural Resources Institute Finland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities, which weakens the functionality of the urban ecosystems and the well-being of citizens. This may also increase the risk of immune-mediated disorders among urban dwellers. In Biodiversity interventions for assisted living centers (BIWE 2), microbial biodiversity interventions are performed to increase biodiversity in urban housing units for people with autism spectrum disorder, disabled people and elderly. Results from the intervention trials are combined with publicly available land cover and ecological data. These are analyzed from the viewpoint of shifts in ecosystems and human well-being and immune regulation, ecological quality, and urban planning. The investigators set up an intervention study in which yards of the housing units are rewilded with diverse vegetation and decaying deadwood and plant residuals. The investigators aim to evaluate the effect of rewilding, and yard management practices on commensal microbiome, cortisol levels and well-being and salivary cytokine levels, and gene pathways.


Description:

Our specific aims are: To assess if rewilding diversifies health-associated skin microbiota and is associated with salivary cytokine levels, gene pathways, cortisol levels and commensal microbiota. Assess whether there are patterns in the microbiome associated with the salivary cytokine levels and hair cortisol levels. Assess whether rewilding affects health and psychological measures. The investigators will recruit approximately 36 study subjects living in assisted housing units in urban areas and aged between 18-82.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 36
Est. completion date September 30, 2027
Est. primary completion date September 30, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 82 Years
Eligibility Inclusion Criteria: - Person lives in assisted living center Exclusion Criteria: - Immunosuppressive medications - Immune deficiencies - a disease affecting immune response (colitis ulcerosa, rheumatoid arthritis, Crohn's disease, diabetes) - cancer diagnosis within the last year or on-going cancer treatment

Study Design


Intervention

Other:
Rewilding
Yards of the assisted living centers will be modified with berry bushes, fruit trees, perennial yard plants, meadow flowers, cultivation boxes, organic mulch materials, decaying deadwood, leaf compost and organic plant growing media with high microbial diversity.

Locations

Country Name City State
Finland Natural Resources Institute Finland Helsinki Uusimaa

Sponsors (2)

Lead Sponsor Collaborator
Natural Resources Institute Finland Tampere University

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Other Associations between environmental factors and primary and secondary outcomes associations between environmental factors (vegetation, deadwood, and polypore richness, land cover categories and other yard characteristics), yard management practices, activities at the yard, salivary cytokine and hair cortisol levels, prevalence of infectious diseases, psychological parameters, and microbial measurements (diversity, and taxonomic and functional features). Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Primary Skin Gammaproteobacteria Change in skin gammaproteobacterial diversity Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Salivary cytokines Interleukin-6 and -10 measured from saliva Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Skin bacteria Changes in skin bacteria are analyzed with Illumina 16s rRNA sequencing. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Saliva microbiota Changes in saliva microbiota are analyzed with shotgun sequencing. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Saliva gene pathways Changes in salivary gene pathways are analyzed with shotgun sequencing. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Cortisol levels Cortisol levels measured from hair samples Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Perceived Stress Scale Decrease in perceived stress scale score during the study period that indicates lower perceived stress levels. Minimum 0, maximum 40. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Warwick-Edinburgh Mental Wellbeing Scale Increase in Warwick-Edinburhg Mental Wellbeing scale score during the study period that indicates better mental well-being. Minimum 14, maximum 70. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Depression Scale Decrease in depression scale score during the study period that indicates lower levels of depression symptoms. Minimum 0, maximum 70. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Nature Relatedness Scale Increase in Nature Relatedness scale during the study period that indicates stronger sense of connectedness to nature. Minimum 6, maximum 30. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Changes in nature contacts Increase in time that study subjects are in contact with nature during the study period. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
Secondary Infectious diseases Infectious diseases are recorded with questionnaires. Baseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year
See also
  Status Clinical Trial Phase
Completed NCT05207956 - App for Strengthening Services In Specialized Therapeutic Support N/A
Completed NCT03286621 - Development of Eye-tracking Based Markers for Autism in Young Children
Completed NCT02608333 - Efficiency of Early Intervention for Autism Spectrum Disorder N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Active, not recruiting NCT06259539 - A YouTube Curriculum for Children With Autism and Obesity N/A
Active, not recruiting NCT06303791 - Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders N/A
Enrolling by invitation NCT05017779 - A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth N/A
Completed NCT04772898 - Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder N/A
Recruiting NCT04987541 - The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder N/A
Completed NCT04308915 - Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders N/A
Completed NCT06038435 - The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder N/A
Terminated NCT04049981 - Investigation of Mechanisms of Action in Superpower Glass Phase 1/Phase 2
Completed NCT03693313 - The Effect of CrossFit Kids on Social Skills in Children With Autism Spectrum Disorder (CrossFit KAMP) N/A
Recruiting NCT04107064 - Achieving Steady Work Among Adults With Autism Through Specialized Employment Program N/A
Recruiting NCT03812068 - Parent-mediated Developmental Behavioral Intervention N/A
Completed NCT03206996 - Exposure Therapy for Auditory Sensitivity in Autism N/A
Completed NCT02299700 - Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder N/A
Completed NCT03422016 - Electroretinogram in Autistic Spectrum Disorders
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Recruiting NCT05114538 - Improving the Part C Early Intervention Service Delivery System for Children With ASD N/A